Exploring the professional and personal impact of migraine: a cross-sectional study in Greece

Background: Migraine is a chronic neurological disorder affecting over one billion individuals globally. It is a leading cause of disability, significantly impacting daily functioning, social relationships and work-related productivity. This study aims to explore the impact of migraine-related disability in everyday life in terms of missed days and productivity loss, as well as to identify work-related difficulties associated with migraine and the potential factors that exacerbate these difficulties. Methods: This cross-sectional study was conducted from October 2023 to June 2024, involving 604 adult patients with migraine in Greece, selected through a convenience sampling method. Data collected included socio-demographic and clinical information, obtained using two validated self-reported questionnaires: the Migraine Disability Assessment (MIDAS) and the HEADWORK questionnaire. Statistical analysis was performed using IBM SPSS (Version 20.0), and descriptive statistics, chi-square tests, t-tests and Spearman’s correlation were employed to evaluate the relationship between disability and work-related challenges. Results: The MIDAS score revealed a high level of disability, with 52.2% of participants classified in the Severe Disability grade. HEADWORK scores highlighted moderate-to-severe work-related difficulties, particularly concerning stress management and environmental factors such as noise and brightness. Females, patients experiencing migraine with aura, and individuals with chronic migraine exhibited higher MIDAS and HEADWORK scores. Conclusions: This study reveals the substantial impact of migraine on professional productivity and social relationships, emphasizing challenges in work-related performance and daily activities. The findings underscore the need for workplace accommodations and targeted interventions to improve the quality of life of individuals with migraine.

Migraine; MIDAS; Disability; HEADWORK; Work difficulties; Productivity

[1] Headache classification committee of the international headache society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018; 38: 1–211.

[2] Saylor D, Steiner T. The global burden of headache. Seminars in Neurology. 2018; 38: 182–190.

[3] Awaki E, Takeshima T, Matsumori Y, Hirata K, Miyazaki N, Takemura R, et al. Impact of migraine on daily life: results of the observational survey of the epidemiology, treatment, and care of migraine (OVERCOME [Japan]) study. Neurology and Therapy. 2024; 13: 165–182.

[4] Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, et al. Migraine. Nature Reviews Disease Primers. 2022; 8: 2.

[5] Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, et al. Migraine: a review on its history, global epidemiology, risk factors, and comorbidities. Frontiers in Neurology. 2022; 12: 800605.

[6] Steiner TJ, Stovner LJ. Global epidemiology of migraine and its implications for public health and health policy. Nature Reviews Neurology. 2023; 19: 109–117.

[7] Pozo-Rosich P, Carmo M, Muñiz A, Armada B, Moya-Alarcón C, Pascual J. Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain. BMC Neurology. 2024; 24: 107.

[8] Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z; Lifting The Burden: the Global Campaign against Headache. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. The Journal of Headache and Pain. 2020; 21: 137.

[9] Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: will health politicians now take notice? The Journal of Headache and Pain. 2018; 19: 17.

[10] de Dhaem OB, Sakai F. Migraine in the workplace. eNeurologicalSci. 2022; 27: 100408.

[11] Wong LP, Alias H, Bhoo-Pathy N, Chung I, Chong YC, Kalra S, et al. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia. The Journal of Headache and Pain. 2020; 21: 68.

[12] Lipton RB, Pozo‐Rosich P, Orr SL, Reed ML, Fanning KM, Dabruzzo B, et al. Impact of monthly headache days on migraine‐related quality of life: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache. 2023; 63: 1448–1457.

[13] Kim Y, Han S, Suh HS. The impact of migraine and probable migraine on productivity loss in Korea: a cross-sectional online survey. PLOS ONE. 2022; 17: e0277905.

[14] Raggi A, Covelli V, Guastafierro E, Leonardi M, Scaratti C, Grazzi L, et al. Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire. The Journal of Headache and Pain. 2018; 19: 85.

[15] D’Amico D, Grazzi L, Curone M, Di Fiore P, Proietti Cecchini A, Leonardi M, et al. Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. Neurological Sciences. 2015; 36: 9–11.

[16] Bigal M, Rapoport A, Lipton R, Tepper S, Sheftell F. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003; 43: 336–342.

[17] Lancaster University. 86 million workdays lost to migraine in the UK every year: migraine costs the UK economy £8.8 billion per year in lost productivity, a new report by the Work Foundation reveals. 2018. Available at: https://www.sciencedaily.com/releases/2018/04/180427144727.htm (Accessed: 18 December 2024).

[18] Raggi A, Covelli V, Leonardi M, Grazzi L, Curone M, D’Amico D. Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurological Sciences. 2014; 35: 23–26.

[19] Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, et al. The cost of headache disorders in Europe: the Eurolight project. European Journal of Neurology. 2012; 19: 703–711.

[20] Dermitzakis EV, Kouroudi A, Argyriou AA, Spingos KC, Bilias K, Vikelis M. Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine. BMC Neurology. 2022; 22: 440.

[21] Constantinidis TS, Arvaniti C, Fakas N, Rudolf J, Kouremenos E, Giannouli E, et al. A population-based survey for disabling headaches in Greece: prevalence, burden and treatment preferences. Cephalalgia. 2021; 41: 810–820.

[22] Oikonomidi T, Vikelis M, Artemiadis A, Chrousos GP, Darviri C. Reliability and validity of the Greek migraine disability assessment (MIDAS) questionnaire. PharmacoEconomics. 2018; 2: 77–85.

[23] Dermitzakis EV, Argyriou AA, Bilias K, Barmpa E, Liapi S, Rikos D, et al. Results of a web-based survey on 2565 Greek migraine patients in 2023: demographic data, imposed burden and satisfaction to acute and prophylactic treatments in the era of new treatment options. Journal of Clinical Medicine. 2024; 13: 2768.

[24] Kouremenos E, Arvaniti C, Constantinidis TS, Giannouli E, Fakas N, Kalamatas T, et al. Consensus of the Hellenic headache society on the diagnosis and treatment of migraine. Τhe Journal of Headache and Pain. 2019; 20: 113.

[25] Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000; 88: 41–52.

[26] Stewart W, Lipton R, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999; 19: 107–114.

[27] D’Amico D, Grazzi L, Grignani E, Leonardi M, Sansone E, Raggi A, et al. HEADWORK questionnaire: why do we need a new tool to assess work‐related disability in patients with migraine? Headache. 2020; 60: 497–504.

[28] Greek Society of Migraine and Headache Patients (GSMHP). About us. 2018. Available at: https://www.kefalalgies.gr (Accessed: 11 October 2023).

[29] Kim BK, Cho SJ, Kim CS, Sakai F, Dodick DW, Chu MK. Disability and economic loss caused by headache among information technology workers in Korea. Journal of Clinical Neurology. 2021; 17: 546.

[30] Sumelahti ML, Sumanen M, Sumanen MS, Tuominen S, Vikkula J, Honkala SM, et al. My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland. The Journal of Headache and Pain. 2020; 21: 118.

[31] Kikui S, Chen Y, Todaka H, Asao K, Adachi K, Takeshima T. Burden of migraine among Japanese patients: a cross-sectional national health and wellness survey. The Journal of Headache and Pain. 2020; 21: 110.

[32] Sakai F, Hirata K, Igarashi H, Takeshima T, Nakayama T, Sano H, et al. A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan. The Journal of Headache and Pain. 2022; 23: 70.

[33] Lipton RB, Buse DC, Adams AM, Varon SF, Fanning KM, Reed ML. Family impact of migraine: development of the impact of migraine on partners and adolescent children (IMPAC) scale. Headache. 2017; 57: 570–585.

[34] Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, et al. Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CAMEO) study. Headache. 2019; 59: 1286–1299.

[35] Shimizu T, Sakai F, Miyake H, Sone T, Sato M, Tanabe S, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. The Journal of Headache and Pain. 2021; 22: 29.

[36] Haw NJ, Cabaluna IT, Kaw GE, Cortez JF, Chua MP, Guce K. A cross-sectional study on the burden and impact of migraine on work productivity and quality of life in selected workplaces in the Philippines. The Journal of Headache and Pain. 2020; 21: 125.

[37] Casas-Limón J, Quintas S, López-Bravo A, Alpuente A, Andrés-López A, Castro-Sánchez MV, et al. Unravelling migraine stigma: a comprehensive review of its impact and strategies for change. Journal of Clinical Medicine. 2024; 13: 5222.

[38] Mangrum R, Bryant AL, Gerstein MT, McCarrier KP, Houts CR, McGinley JS, et al. The impacts of migraine on functioning: results from two qualitative studies of people living with migraine. Headache. 2024; 64: 156–171

[39] Steenberg JL, Thielen K, Hansen JM, Hansen ÅM, Rueskov V, Nabe-Nielsen K. Demand-specific work ability among employees with migraine or frequent headache. International Journal of Industrial Ergonomics. 2022; 87: 103250.

[40] Peles I, Sharvit S, Zlotnik Y, Gordon M, Novack V, Waismel-Manor R, et al. Migraine and work–beyond absenteeism: migraine severity and occupational burnout—a cohort study. Cephalalgia. 2024; 44: 03331024241289930.

[41] Magnavita N. Headache in the workplace: analysis of factors influencing headaches in terms of productivity and health. International Journal of Environmental Research and Public Health. 2022; 19: 3712.

[42] Fernandes C, Dapkute A, Watson E, Kazaishvili I, Chądzyński P, Varanda S, et al. Migraine and cognitive dysfunction: a narrative review. The Journal of Headache and Pain. 2024; 25: 221.

[43] Begasse De Dhaem O, Gharedaghi MH, Bain P, Hettie G, Loder E, Burch R. Identification of work accommodations and interventions associated with work productivity in adults with migraine: a scoping review. Cephalalgia. 2021; 41: 760–773.

[44] Knauf C, Heinrichs K, Süllwold R, Icks A, Loerbroks A. Migraine self-management at work: a qualitative study. Journal of Occupational Medicine and Toxicology. 2024; 19: 22.

[45] Riccò M, Ferraro P, Camisa V, Di Palma P, Minutolo G, Ranzieri S, et al. Managing of migraine in the workplaces: knowledge, attitudes and practices of Italian occupational physicians. Medicina. 2022; 58: 686.

[46] Appel AM, Török E, Jensen MA, Garde AH, Hansen ÅM, Kaerlev L, et al. The longitudinal association between shift work and headache: results from the Danish PRISME cohort. International Archives Occupational and Environmental Health. 2020; 93: 601–610.

[47] Godley III F, Meitzen J, Nahman-Averbuch H, O’Neal MA, Yeomans D, Santoro N, et al. How sex hormones affect migraine: an interdisciplinary preclinical research panel review. Journal of Personalized Medicine. 2024; 14: 184.

[48] Mehmood K, Ansari T, Niaz A. Gender-based difference in quality of life of migraine sufferers: a cross-sectional study. Annals of Abbasi Shaheed Hospital and Karachi Medical & Dental College. 2024; 29: 136–142.

[49] Matsumori Y, Ueda K, Komori M, Zagar AJ, Kim Y, Jaffe DH, et al. Burden of migraine in japan: results of the observational survey of the epidemiology, treatment, and care of migraine (overcome [Japan]) study. Neurology and Therapy. 2022; 11: 205–222.

[50] Papakonstantinou D, Tomos C. Workplace productivity loss as a result of absenteeism and presenteeism in chronic and episodic migraine: a scoping review. International Journal of Workplace Health Management. 2022; 15: 38–53.

[51] Walsh LE, Carter-Bawa L. Using social media to recruit individuals for health-related research: feasibility and lessons learned. Journal of Health Psychology. 2023; 28: 599–606.

[52] Wu MJ, Zhao K, Fils-Aime F. Response rates of online surveys in published research: a meta-analysis. Computers in Human Behavior Reports. 2022; 7: 100206.

[53] Ford JH, Jackson J, Milligan G, Cotton S, Ahl J, Aurora SK. A real‐world analysis of migraine: a cross‐sectional study of disease burden and treatment patterns. Headache: The Journal of Head and Face Pain. 2017; 57: 1532–1544.

[54] Agosti R, Parzini C, Findling O, Myers P, Petersen JA, Ryvlin P, et al. Prevalence and burden of migraine in Switzerland: cross-sectional study in ten specialised headache centres from the BECOME study. Pain and Therapy. 2023; 12: 575–591.

[55] Sakai F, Igarashi H, Yokoyama M, Begasse de Dhaem O, Kato H, Azuma Y, et al. Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees. Cephalalgia. 2023; 43: 03331024231165682.

[56] Dione MN, Donelle L, Smye V, Befus D. Self-management experience of nurses living with migraine: a qualitative study. Canadian Journal of Nursing Research. 2024; 56: 38–48.

[57] Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, et al. Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study. Headache. 2022; 62: 122–140.

[58] Peles I, Asla M, Abayev M, Gordon M, Novack V, Ribalov R, et al. Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting. The Journal of Headache and Pain. 2022; 23: 160.